BioPharma APAC

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...

January 07, 2022 | News

OrganOx receives FDA approval for its liver normothermic machine perfusion system

The OrganOx metra is a fully automated NMP device for the preservation and transport of donor livers destined for transplantation. The marketing ...

December 30, 2021 | News

Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human

The endovascular intervention surgical robot, combined with Digital Subtraction Angiography (DSA), precisely evaluated the target lesion and its location, ...

November 25, 2021 | News

Smart thyroid hormone test launched

Swiss medtech company Bloom Diagnostics has launched its Bloom Thyroid Test to help detect hypothyroidism. Bloom Diagnostics is an innovative medtech compa...

November 19, 2021 | News

Baxter Indonesia launches My Kidney Journey portal

Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch of My Kidney Journey (www.infoginjal.com), a...

November 16, 2021 | News

Mentice receives order of total SEK 7.0 million from ABBOTT

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has...

October 19, 2021 | News

FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia

"Today's action marks the first FDA approval of a therapy to treat this very rare and devastating disease in children," said Peter Marks, M.D., Ph.D.,...

October 11, 2021 | News

Indonesia Bring New Hope to Women With Endometriosis

Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today ...

October 07, 2021 | News

Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market Mirum P...

September 23, 2021 | News

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy...

September 17, 2021 | News

Everest to support future development and commercialization globally for the treatment of renal diseases

Collaboration consolidates Everest's leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $5...

September 17, 2021 | News

Abbott to treat minimally invasive patients with aortic valve disease

The catheter aortic valve implantation (TAVI) procedure treats people with severe and symptomatic aortic snoosis whose surgical risk is considered high or ...

September 03, 2021 | News

Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment fo...

August 31, 2021 | News

HUAWEI, Aligns With PLANO to Tackle the Global Problem of Myopia

Huawei Technologies Co. Ltd. (hereinafter, Huawei) and Plano Pte. Ltd. (hereinafter, Plano) today announced their partnership to address the global problem...

August 05, 2021 | News

Stay Connected